Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea

• Prif Awduron: Alano Martins Pedrosa (Awdur), Maritza Cavalcante Barbosa (Awdur), Thayna Nogueira dos Santos (Awdur), Luzia Kalyne Almeida Moreira Leal (Awdur), Amanda de Araújo Lopes (Awdur), Darcielle Bruna Dias Elias (Awdur), Greyce Luri Sasahara (Awdur), Bruno Coêlho Cavalcanti (Awdur), Romélia Pinheiro Gonçalves (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Universidade de São Paulo, 2014-04-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.
• Notes: 2175-9790; 10.1590/S1984-82502014000200020
• Keywords: Hidroxiuréia/citotoxicidade; Anemia falciforme/tratamento; Neutrófilos/lesão ao DNA; Ácido desoxirribonucleico/lesão; Pharmacy and materia medica; RS1-441
• Source: Brazilian Journal of Pharmaceutical Sciences, Vol 50, Iss 2, Pp 401-410 (2014)

Hydroxyurea (HU) is the most important advance in the treatment of sickle cell anaemia (SCA) for preventing complications and improving quality of life for patients. However, some aspects of treatment with HU remain unclear, including their effect on and potential toxicity to other blood cells such as neutrophils. This study used the measurement of Lactate Dehydrogenase (LDH) and Methyl ThiazolTetrazolium (MTT) and the comet assay to investigate the cytotoxicity and damage index (DI) of the DNA in the neutrophils of patients with SCA using HU.In the LDH and MTT assays, a cytoprotective effect was observed in the group of patients treated, as well as an absence of toxicity. When compared to patients without the treatment, the SS group (n=20, 13 women and 07 men, aged 18-69 years), and the group of healthy individuals (AA) used as a control group (n=52, 28 women and 24 men, aged 19-60 years), The SSHU group (n=21, 11 women and 10 men, aged 19-63 years) showed a significant reduction (p<0.001) in LDH activity and an increase in the percentage of viable cells by the MTT (p<0.001). However, the SSHU group presented significantly higher DI values (49.57±6.0 U/A) when compared to the AA group (7.43 ± 0,94U/A) and the SS group (22.73 ±5.58 U/A) (p<0.0001), especially when treated for longer periods (>20 months), demonstrating that despite the cytoprotective effects in terms of cell viability, the use of HU can induce DNA damage in neutrophils.